Fellowship · Charlottesville, VA
Sponsored by University of Virginia Medical Center
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
The New England journal of medicine · 2025 · 748 citations · Christopher Kramer
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy.
Journal of the American College of Cardiology · 2025 · 147 citations · Christopher Kramer
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial.
Nature medicine · 2025 · 111 citations · Christopher Kramer
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.
Journal of the American College of Cardiology · 2025 · 84 citations · Kenneth Bilchick
Left Bundle Branch Area Pacing for Cardiac Resynchronization Therapy: Results From the International LBBAP Collaborative Study Group.
JACC. Clinical electrophysiology · 2021 · 334 citations · Dominik Beer
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
Journal of the American College of Cardiology · 2023 · 175 citations ·
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
The Journal of thoracic and cardiovascular surgery · 2023 · 125 citations · Christopher Kramer
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity.
Nature genetics · 2021 · 272 citations · Christopher Kramer